Notably, the favourable effects found in AD patients with APOE-ε4 genotype is also in accordance with previous work demonstrating that APOE-ε4 carriers display greater improvements in cognitive functions in response to exercise compared to non-carriers (37). This evidence concerns the gene APOE and Alzheimer disease.